chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: HPV9
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a registered nurse and refers to multiple patients of an unknown gender and age. The patients' concurrent conditions, medical history and concomitant therapy were not reported. On unknown dates, the patients were vaccinated with an unspecified number of doses of improperly stored GARDASIL 9 lot # L014415 expiration date: 25-JUL-2017 (dose and route of administration were not reported). There were no adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 02-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L023385, expiration date: 25-JUN-2017) (Incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a licensed vocational nurse (LVN) referring to an unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with doses of improperly stored ROTATEQ (lot # K020181, exp. date: 24-JUN-2016; K024700, exp. 30-JUL-2016; L013192, exp. 19-JAN-2017; strength,, dosage and frequency unspecified) orally. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 28-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L023385, expiration date: 25-JUN-2017). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a registered nurse and refers to multiple patients of an unknown gender and age. The patient's concurrent conditions, medical history and concomitant therapy were not reported. On unknown dates, the patients were vaccinated with an unspecified number of doses of improperly stored ROTATEQ lot # K020181 expiration date: 24-JUN-2016 (dose was not reported; orally). There were no adverse effects reported. This is one  of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 30-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L023385, expiration date: 25-JUN-2017). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: F
Vaccine: PPV
Symptoms: Injection site pain
Clinical narrative: This spontaneous report was received from a female nurse of unknown age, reporting on herself. The patient's concurrent conditions, medical history or concomitant medications were not reported. On an unknown date, the patient received PNEUMOVAX 23 (strength, dose, route, site of administration, lot # and expiry date were not reported) and "it hurt". She additionally reported that injection of PNEUMOVAX 23 was painful for most patients. The outcome of adverse event was not reported. The causality assessment between adverse event and PNEUMOVAX 23 was not provided. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 04-DEC-2015, the patient was vaccinated with improperly stored dose of VARIVAX (Merck) lot # L021214, expiry date 10-JUN-2017 (strength, dose, route of administration and anatomical location were not reported). No adverse effects were reported. Product quality complaint (PQC) was not reported. This is one of several reports received from the same source. Additional information has been requested.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Contusion, Headache, Hypoaesthesia, Peripheral swelling
Clinical narrative: This spontaneous report was received from a pharmacist concerning to a 68-year-old female patient. The patient had none of pertinent medical history, drug reactions or allergies. On 14-DEC-2015, the patient was vaccinated with a dose of ZOSTAVAX (0.65 ml/once, lot # L021610, expiration date 10-SEP-2016), subcutaneously. Concomitant therapies included FIORICET, zolpidem, albuterol sulfate (manufacturer unknown), tramadol hydrochloride, pravastatin, omeprazole (manufacturer unknown), montelukast, diltiazem, lisinopril (manufacturer unknown), PROAIR, ADVAIR and FLONASE. On 17-DEC-2015, the patient's interpreter called to the pharmacy and stated that the patient's arm was swollen, there was bruising, patient could not feel her hand and she had a headache. The lab diagnostic tests were not performed. There was no treatment given for the events. The patient did not seek medical attention. The outcome of the events was reported as not recovered/not resolved. The relatedness between the events and ZOSTAVAX was not provided. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 25-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L023385, expiration date: 25-JUN-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 27-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L023385, expiration date: 25-JUN-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 01-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 18-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L008684, expiration date: 13-MAR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. No medical history, concurrent condition or concomitant medication was reported. On an unknown date, the patient was vaccinated with improperly stored VARIVAX (Merck) lot # L026405, expiry date 15-JUL-2017 (dose, route and site of administration were not reported). No adverse effects were reported. No product quality complaint (PQC) was reported. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 23-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 29-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a registered nurse and refers to multiple patients of an unknown gender and age. The patients' concurrent conditions, medical history and concomitant therapy were not reported. On unknown dates, the patients were vaccinated with an unspecified number of doses of improperly stored VAQTA lot # L002717, expiration date: 02-JUN-2017 (dose and route of administration were not reported). There were no adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 17-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L008684, expiration date: 13-MAR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a licensed vocational nurse (LVN) referring to an unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with doses of improperly stored GARDASIL (lot # K011562, exp. date: 08-APR-2017; K016966, exp. 10-MAY-2017; L006549, exp. 06-APR-2017; strength, dosage, frequency and route unspecified). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 17-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a licensed vocational nurse (LVN) referring to an unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with doses of improperly stored VARIVAX (Merck) (lot # K009756, exp. date: 09-JUL-2016; L015047, exp. 29-APR-2017; L020000, exp. 02-JUN-2017; L021214 exp 10-JUN-2017; strength, dosage, frequency and route unspecified) (incorrect product storage). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a licensed vocational nurse (LVN) referring to an unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with doses of improperly stored VAQTA (lot # L004742, exp. date: 18-AUG-2016; strength, dosage, frequency and route unspecified). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a licensed vocational nurse (LVN) referring to an unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with doses of improperly stored RECOMBIVAX HB lot # L016427, exp. date: 13-APR-2017; strength, dosage, frequency and route unspecified. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 20-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 18-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 19-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 21-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Myalgia, Peripheral swelling
Clinical narrative: Information has been received from a pharmacist referring to a 67 year old female patient. The patient's pertinent medical history included diabetes, diverticulitis and high cholesterol. The patient's history drug included PREVNAR 13 which was vaccinated on an unknown date in 2014. The patient did not have drug reactions. On 14-DEC-2015 the patient was vaccinated with a dose of PNEUMOVAX 23 (lot # K010466, expiration date 23-MAR-2016, dose was unknown) intramuscularly. On the same day at night, the patient's arm (where she received the injection) began to hurt. On 15-DEC-2015, the patient's arm (same as the one she received the injection) became red and swollen down to the "mid forearm" and has severe pain in the muscle that "attached the arm to the" breast. The patient took ADVIL for the pain. No lab diagnostics studies were performed. The outcome of the events was reported as not recovered/not resolved. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a registered nurse and refers to multiple patients of an unknown gender and age. The patients' concurrent conditions, medical history and concomitant therapy were not provided. On unknown dates, the patients were vaccinated with an unspecified number of doses of improperly stored PROQUAD (Merck), lot #L032757, expiration date: 24-FEB-2017 (dose and route of administration were not reported). There were no adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 24-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 25-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 27-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot #L012479, expiration date: 10-APR-2017). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 27-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (Incorrect product storage). No adverse effects reported. This is one of several report from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 27-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 28-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 30-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 02-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 02-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012482, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 09-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a healthcare worker refers to multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medication were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of ZOSTAVAX lot # I021610, expiration date 10-SEP-2016 (route of administration and dose were not reported). No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 11-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 23-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L023385, expiration date: 25-JUN-2017). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 10-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a registered nurse and refers to multiple patients of an unknown gender and age. The patients' concurrent conditions, medical history and concomitant therapy were not reported. On unknown dates, the patients were vaccinated with an unspecified number of doses of improperly stored VARIVAX (Merck) lot # L001335, expiration date: 13-JAN-2017 (dose and route of administration were not reported). There were no adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 21-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L023385, expiration date: 25-JUN-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 23-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L023385, expiration date: 25-JUN-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Age: 13.0
Sex: M
Vaccine: HPV4
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: This spontaneous report as received from a physician refers to a 13 year old male patient. No medical history or concurrent conditions were reported. The patient was vaccinated with the first, the second and the third dose of GARDASIL (indication, dose, lot# and expiration date were not provided) on 29-JUL-2013, 02-APR-2014 and on 04-AUG-2014, respectively. On 16-DEC-2015, the patient was vaccinated with GARDASIL 9 (indication not provided, 0.5 ml, lot# L007560, expiration date 15-JUN-2017), intramuscularly. No concomitant medications were reported. No adverse effects were reported. Additional information has been requested.
Age: 17.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a nurse regarding a 17 year old patient of unknown gender. No historical or concurrent medications were reported. On 30-NOV-2015, the patient was vaccinated with a dose of improperly-stored GARDASIL (lot # K011562 and expiry: 08-APR-2017). This dose of GARDASIL was the patient's third dose in her HPV series. No adverse experience was reported. No product quality complaint (PQC) was reported. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a registered nurse and refers to multiple patients of an unknown gender and age. The patients' concurrent conditions, medical history and concomitant therapy were not reported. On unknown dates, the patients were vaccinated with an unspecified number of doses of improperly stored RECOMBIVAX HB 0.5microgram/0.5ml, lot # L018501, expiration date: 22-JUN-2017 (dose and route of administration were not reported). There were no adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 19-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L023385, expiration date: 25-JUN-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Age: 0.2
Sex: U
Vaccine: HEPA
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant and refers to a 2 month old patient of unknown gender. The patient's concurrent conditions, medical history or concomitant medications were not reported. On 21-DEC-2015, the patient was vaccinated with VAQTA, 0.5 ml, intramuscularly, lot# L032749, expiry date 04-NOV-2016 (site of administration was not reported). No adverse effects were reported. No product quality complaint (PQC) was involved. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 08-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to two patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On 19-NOV-2015, the patients were vaccinated with improperly stored doses of VARIVAX (Merck) lot # L021214, expiry date 10-JUN-2017 (strength, dose and route of administration, anatomical location were not reported). No adverse effects were reported. Product quality complaint (PQC) was not reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 03-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012482, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a healthcare worker refers to multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medication were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of VARIVAX (Merck) lot # L023588 and expiration date 26-JUN-2017, lot # L031066 and expiration date 18-AUG-2017, lot # K003423 and expiration date 06-MAR-2016, lot # K002920 and expiration date 26-FEB-2016 (route of administration and dose were not reported). No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 07-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 19-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L020189, expiration date: 03-JUN-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 01-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012482, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Age: 75.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: This spontaneous report was received from a medical assistant regarding a 75 year old male patient. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On 08-SEP-2015, the patient was vaccinated with a dose of PNEUMOVAX 23 (dose: 0.5 ml, lot # K007824, expiration date 05-NOV-2015, via intramuscular route in deltoid on an unspecified arm). On an unspecified day in 2015, the patient experienced excess swelling and redness at injection site and it was very bad. The patient sought medical attention via coming to the office and received treatment with unspecified topical cream. The patient's outcome was recovered (in 2015). The relatedness between the events and the vaccination with PNEUMOVAX 23 was not provided. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 18-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L020189, expiration date: 03-JUN-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 04-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012482, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 05-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012482, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Age: 46.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: This spontaneous report was received from a medical assistant regarding a 46 year old male patient. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On 16-DEC-2015, the patient was vaccinated with a dose of PNEUMOVAX 23 (dose: 0.5 ml, lot # L019835, expiration date 23-MAR-2017, via intramuscular route in deltoid in an unspecified arm). In December 2015, the patient experienced excess swelling and redness at injection site and it was very bad. The patient sought medical attention via coming to the office and received treatment with unspecified topical cream. The patient's outcome was recovered (in December 2015). The relatedness between the events and the vaccination with PNEUMOVAX 23 was not provided. This is one of several reports received from the same source. Additional information has been requested.
Age: 59.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: This spontaneous report was received from a medical assistant regarding a 59 year old female patient. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On 11-DEC-2015, the patient was vaccinated with a dose of PNEUMOVAX 23 (dose: 0.5 ml, lot # L038522, expiration date 11-AUG-2017, via intramuscular route in the deltoid on an unspecified arm). In December 2015, the patient experienced excess swelling and redness at injection site and it was very bad. The patient sought medical attention via coming to the office and received treatment with unspecified topical cream. The patient's outcome was recovered (in December 2015). The relatedness between the events and the vaccination with PNEUMOVAX 23 was not provided. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 17-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L020189, expiration date: 03-JUN-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from health care worker refers to unspecified patients of unknown age and gender. Patients' current conditions and pertinent medical history was not provided. On unknown dates, unspecified patients have been was vaccinated with ROTATEQ lot # K016261 and expiration date; 23-JUN-2016, (dose, strength, vaccination site was not provided) which have been exposed to temperatures outside of the recommended range since the excursion on 17-09-2015. Concomitant medication was not reported. No adverse experience has been reported. The outcome of the event reported was unknown. There was no product quality complaint involved. No additional information was provided. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 05-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012482, expiration date: 10-APR-2017) (Incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 28-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012482, expiration date: 10-APR-2017) (Incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 11-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012482, expiration date: 10-APR-2017) (Incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to multiple unspecified patients of an unknown age and unknown gender. On multiple unspecified dates, the multiple unspecified patients were vaccinated with improperly stored doses of VARIVAX (Merck) (lot # L020003, expiration date: 02-JUN-2015) (dose, strength, dose number, vaccination site, route of administration was not provided). There were no adverse effects reported. It was also reported that reporter inquired about the stability of VARIVAX (Merck) with lot # L026410 and expiration date; 15-FEB-2015, but none of this lot number and expiration date of VARIVAX (Merck) has been administered to patients. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 07-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012482, expiration date: 10-APR-2017) (Incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 09-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012482, expiration date: 10-APR-2017) (Incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. No medical history or concomitants medications were reported. On unknown dates, the patients were vaccinated with improperly stored VARIVAX (lot# L007225, expiration date 03-MAR-2017; lot # K006137, expiration date 29-APR-2016) (dosage schedules were not reported). No adverse event was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 08-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012482, expiration date: 10-APR-2017) (Incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. No medical history or concomitants medications were reported. On unknown dates, the patients were vaccinated with improperly stored PROQUAD (lot# 008353, expiration date: 11-SEP-2016; lot# L003221, expiration date: 30-JUL-2016)(dosage schedule was not reported). No adverse event was reported. This is one of several reports received fro, the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 02-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012482, expiration date: 10-APR-2017) (Incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 30-NOV-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012482, expiration date: 10-APR-2017) (incorrect product storage). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Age: 73.0
Sex: F
Vaccine: FLU3
Symptoms: Paraesthesia, Pharyngeal paraesthesia, Throat irritation
Clinical narrative: Shortly after patient was vaccinated, she started to feel an itching, tingling feeling in her throat.  Fearing that it was an allergic reaction, I called 911.  The patient remained alert, talking and breathing normally until paramedics arrived, though she stated that she started to feel additional tingling in her arms and chest.  She was transported by ambulance to emergency department. No treatment administered before paramedics arrived.
Age: 65.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site pain
Clinical narrative: Soreness at injection site.  Soreness continuing after 2 weeks following injection.
Age: 0.68
Sex: F
Vaccine: PPV
Symptoms: Diarrhoea, Insomnia, Irritability, Pyrexia
Clinical narrative: Fever over 102. Fussiness. Loose stool. Lack of sleep.
Age: 76.0
Sex: M
Vaccine: FLU3
Symptoms: Asthenia, Chills, Diarrhoea, Dizziness, Thirst
Clinical narrative: Several incidents of intense vomiting and diarrhea between 9:00 PM and 7:00 AM accompanied by mild chllls. Weakness and mild dizziness in the morning. Another 3 hours of deep sleep required to re stabilize, followed by acute thirstiness.
Age: 76.0
Sex: M
Vaccine: FLU3
Symptoms: Vomiting
Clinical narrative: Several incidents of intense vomiting and diarrhea between 9:00 PM and 7:00 AM accompanied by mild chllls. Weakness and mild dizziness in the morning. Another 3 hours of deep sleep required to re stabilize, followed by acute thirstiness.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Decreased appetite, Headache, Malaise, Parotid gland enlargement, Pyrexia
Clinical narrative: Extremely swollen parotid glands, fever, headache, malaise, loss of appetite.
Age: 64.0
Sex: F
Vaccine: FLUX, VARZOS, FLUX, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Musculoskeletal pain, Neck pain
Clinical narrative: Swelling, redness at site- 3" X 5" hard painful to touch, pain in shoulder and neck like a pinched nerve which hasn't gone away.
Age: 30.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Injection Site reaction: Swelling and redness at sight of injection.
Age: 48.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Drug administered at inappropriate site, Injection site pain
Clinical narrative: Shoulder still hurts more than 8 weeks after shot. Patient states that she thinks it's because the shot was given too close to the shoulder. Her ortho thinks so.
Age: 48.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Drug administered at inappropriate site, Injection site pain, Musculoskeletal pain
Clinical narrative: Shoulder still hurts more than 8 weeks after shot. Patient states that she thinks it's because the shot was given too close to the shoulder. Her ortho thinks so.
Age: 53.0
Sex: F
Vaccine: FLU4
Symptoms: Musculoskeletal pain
Clinical narrative: Patient still had shoulder pain more than 8 weeks after shot given.
Age: 40.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Large red circle formed around injection sight that was hard and elevated and hot to the touch.  Lasted 4 days.
Age: 3.0
Sex: F
Vaccine: FLUN4
Symptoms: Chills, Decreased appetite, Diarrhoea, Pain, Pyrexia
Clinical narrative: 102 Fever, no appetite, vomiting, Diarrhea, chills, body aches.
Age: 3.0
Sex: F
Vaccine: FLUN4
Symptoms: Vomiting
Clinical narrative: 102 Fever, no appetite, vomiting, Diarrhea, chills, body aches.